美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

iShares Health Innovation Active ETF

33.32

+0.10420.31%

盤後：33.23-0.0850-0.26%16:10 EDT

成交量：583

成交額：1.94萬

市值：1,332.60萬

市盈率：- -

高：33.32

開：33.23

低：33.23

收：33.21

52周最高：34.86

52周最低：25.79

股本：40.00萬

流通股本：40.00萬

量比：0.29

換手率：0.15%

股息：0.08

股息率：0.24%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

維康藥業(300878.SZ)：黃甲軟肝顆粒獲批開展用於慢性乙型病毒性肝炎肝纖維化的III期臨床試驗

維康藥業：黃甲軟肝顆粒獲III期臨床試驗補充申請批准

興齊眼藥(300573.SZ)：SQ-25012注射液獲得臨床試驗批准通知書

興齊眼藥：SQ-25012注射液獲臨床試驗批准通知書

港股異動 | 海西新藥(02637)升逾3% 近期已遞交HX9428的DME IIa期新藥臨床試驗申請

強生：瑞布侖特法斯普羅聯合拉茲克魯澤治療一年，因治療相關事件停藥率不足1%

強生試驗性抑鬱症藥物未達中期研究主要目標

Contineum與強生合作的抑鬱症藥物未能達到中期試驗目標

默沙東高管：上調700億美元業績預測的時機「尚待確定」但「勢在必行」

默沙東： 340B 項目及相關政策的潛在變化或將帶來利好，但對業務影響有限。

默沙東高管：340B政策與政策演變或成順風因素，但對業務無實質性影響——摩根士丹利會議紀要

BUZZ——美國股市動態-美國能源股、鮑德温、強生

強生表示，在一項非小細胞肺癌研究中，RYBREVANT聯合化療可將死亡風險降低43%。

強生Rybrevant®聯合化療在EGFR外顯子20插入突變陽性肺癌中展現迄今最長中位總生存期

有報導稱阿波羅正就收購強生公司骨科業務部門進行談判，受此消息提振，強生股價上漲

有報道稱阿波羅正就收購強生公司骨科業務部門進行談判，受此消息提振，強生股價上漲

強生骨科，買家浮出水面

赛柏蓝器械

博安生物：BA1203獲准開展臨床試驗

南方财经网

康哲藥業(00867)：創新藥高選擇性TYK2抑制劑CMS-D001 獲得系統性紅斑狼瘡適應症藥物臨床試驗批准通知書

康哲藥業：9月14日CMS-D001獲SLE臨床試驗批准

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/BMED/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":33.315,"timestamp":1789502400000,"preClose":33.2108,"halted":0,"volume":583,"hourTrading":{"tag":"盘后","latestPrice":33.23,"preClose":33.315,"latestTime":"16:10 EDT","volume":6,"amount":199.89,"timestamp":1789503006991,"change":-0.085,"changeRate":-0.002551,"amplitude":0},"delay":0,"changeRate":0.0031375335734158388,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"未開盤","change":0.1042,"latestTime":"09-15 16:00:00 EDT","open":33.23,"high":33.315,"low":33.23,"amount":19399,"amplitude":0.002559,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":33.2108,"sharesOutstanding":360000,"nav":33.210436,"aum":13284174.4,"dividendRate":0.002392,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.23,"preClose":33.315,"latestTime":"16:10 EDT","volume":6,"amount":199.89,"timestamp":1789503006991,"change":-0.085,"changeRate":-0.002551,"amplitude":0},"volumeRatio":0.294683,"impliedVol":0.0634,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.294683,"shares":400000,"dividePrice":0.0797,"high":33.315,"amplitude":0.002559,"preClose":33.2108,"low":33.23,"week52Low":25.794,"pbRate":"--","week52High":34.86,"institutionHeld":0,"latestPrice":33.315,"eps":0,"divideRate":0.002392,"volume":583,"delay":0,"ttmEps":0,"open":33.23,"prevYearClose":30.32,"prevWeekClose":32.965,"prevMonthClose":33.8091,"prevQuarterClose":30.62,"fiveDayClose":33.33,"twentyDayClose":32.4416,"sixtyDayClose":28.4203},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667832610","title":"維康藥業(300878.SZ)：黃甲軟肝顆粒獲批開展用於慢性乙型病毒性肝炎肝纖維化的III期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2667832610","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667832610?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 16:15","pubTimestamp":1789460131,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维康药业(300878.SZ)发布公告，公司于近日收到国家药品监督管理局核准签发的黄甲软肝颗粒的《药物临床试验补充申请批准通知书》，经审查，黄甲软肝颗粒临床试验申请符合药品注册的有关要求，在进一步完善临床试验方案的基础上，同意开展用于慢性乙型病毒性肝炎肝纤维化的III期临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496180.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300878","PSYK","BMED","IBBJ","IBBQ","BK0239","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661724","title":"維康藥業：黃甲軟肝顆粒獲III期臨床試驗補充申請批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661724","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661724?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 16:07","pubTimestamp":1789459662,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBJ","PSYK","IBBQ","MDTX","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667617527","title":"興齊眼藥(300573.SZ)：SQ-25012注射液獲得臨床試驗批准通知書","url":"https://stock-news.laohu8.com/highlight/detail?id=2667617527","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667617527?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 15:54","pubTimestamp":1789458841,"startTime":"0","endTime":"0","summary":"智通财经APP讯，兴齐眼药(300573.SZ)发布公告，近日，公司收到国家药品监督管理局签发的关于SQ-25012注射液的《药物临床试验批准通知书》，同意本品开展拟用于治疗甲状腺眼病的临床试验。SQ-25012注射液是一款重组人源化IgG1型三特异性抗体，为公司研发的治疗用生物制品1类创新药，临床拟用于治疗甲状腺眼病。根据创新型治疗用生物制品1类注射剂的有关要求，公司已经完成SQ-25012注射液药学及非临床药理毒理学等多方面的研究，研究结果表明SQ-25012注射液具有良好的安全性及临床开发价值。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496171.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300573","IBBQ","MDTX","PSYK","BMED","BK0239","IBBJ","BK0177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667617589","title":"興齊眼藥：SQ-25012注射液獲臨床試驗批准通知書","url":"https://stock-news.laohu8.com/highlight/detail?id=2667617589","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667617589?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 15:51","pubTimestamp":1789458674,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDTX","BMED","PSYK","IBBQ","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667148376","title":"港股異動 | 海西新藥(02637)升逾3% 近期已遞交HX9428的DME IIa期新藥臨床試驗申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2667148376","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667148376?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 14:48","pubTimestamp":1789454932,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，海西新药涨超3%，截至发稿，涨2.89%，报195.5港元，成交额618.26万港元。消息面上，海西新药发布公告，本公司自主研发的创新药项目HXP056的候选药物分子HX9428，已于2026年8月31日正式向中国国家药品监督管理局药品审评中心递交新适应症糖尿病性黄斑水肿的IIa期新药临床试验申请。公司表示，将继续全力推进HX9428在中美两地多项临床研究的进展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496128.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","KCAI","VXUS","BMED","BK4588","IBBQ","BK1191","IBBJ","PSYK","02637","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194954760","title":"強生：瑞布侖特法斯普羅聯合拉茲克魯澤治療一年，因治療相關事件停藥率不足1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194954760","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194954760?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 11:03","pubTimestamp":1789441392,"startTime":"0","endTime":"0","summary":"强生公司披露了一项令人振奋的临床数据——在接受瑞布仑特法斯普罗（Rybrevant Faspro）与拉兹克鲁泽（Lazcluze）联合治疗方案的患者群体中，经过整整一年的治疗周期，因治疗相关不良事件而选择终止用药的比例，竟低于1%。这一数字无疑为这款联合疗法在临床实践中的耐受性写下了一份极具说服力的注脚。换言之，绝大多数患者不仅能够坚持完成长期治疗，而且在整个过程中所承受的药物相关副作用，鲜少达到需要中断治疗的严重程度。强生方面强调，这一低停药率数据，从耐受性维度为该联合方案提供了坚实的循证支持，也进一步巩固了其在相关适应症治疗格局中的地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0069063385.USD","IE00B19Z3581.USD","LU2487616109.SGD","IHE","LU2133065610.SGD","BK4532","LU0345770308.USD","LU2756315664.SGD","SGXZ80539844.SGD","SG9999001176.SGD","IE00BDGV0183.EUR","IXJ","SG9999001440.SGD","SG9999001176.USD","IE0009355771.USD","LU2417539215.USD","LU0943347566.SGD","LU1162221912.USD","BK4592","IE00B42XCP33.USD","LU1059921491.USD","FHLC","IE00BN8TJ469.HKD","LU0689626769.HKD","LU2430703178.SGD","GDOC","LU0203347892.USD","IE00BJT1NW94.SGD","LU0795875169.SGD","LU1221951129.SGD","LU0124676726.USD","LU0320765646.SGD","LU1894683348.USD","LU0994945656.USD","LU1674673428.USD","IE00B3T34201.USD","RXL","IE000F7OJYX1.SGD","LU0057025933.USD","IE000SO60NU8.SGD","LU0889566641.SGD","LU0787776722.HKD","BK4504","LU1066053197.SGD","LU1551013342.USD","LU0345769128.USD","LU0640476718.USD","LU1023059063.AUD","LU1551013425.SGD","BK4568","LU1585245621.USD","LU2471134952.CNY","LU0058720904.USD","LU1244550221.USD","LU2592432038.USD","MEDX","LU1043141396.HKD","LU2023250330.USD","JDOC","LU2129689431.USD","LU2430703095.HKD","FTXH","LU2089984988.USD","LU1629891620.HKD","LU1732799900.SGD","LU0792757196.USD","IE00B2B36J28.USD","SG9999002232.USD","LU1935042991.SGD","IE00BLSP4239.USD","LU2750360997.AUD","BK4585","LU2750360641.GBP","PJP","SG9999002224.SGD","LU0820561818.USD","LU1280957306.USD","LU0689472784.USD","SG9999013999.USD","LU1261432733.SGD","TRUH","LU0210536198.USD","LU0432979614.USD","IE00BKVL7J92.USD","LU0289739343.SGD","LU2236285917.USD","LU2213496289.HKD","LU2403377893.USD","IE00B3PB1722.GBP","LU1929549753.HKD","IE000MB6IJN5.SGD","LU1732800096.USD","LU1244550577.SGD","IE000BZT7R73.USD","IE0002270589.USD","LU0345770993.USD","IE0000B7K699.USD","LU1057294990.SGD","LU2471134879.HKD","XLV","LU0053666078.USD","VHT","IE000M9KFDE8.USD","LU0122379950.USD","LU2471134523.USD","SGXZ57979304.SGD","LU0882574055.USD","LU2129689605.HKD","IE00BVYPNW00.USD","BK4581","LU0912757837.SGD","LU1061106388.HKD","LU1121112475.USD","LU2456880835.USD","LU2505996509.AUD","LU0289739699.SGD","LU0345769631.USD","IE00BJJMRZ35.SGD","LU1066051498.USD","LU2896262040.SGD","LU0114720955.EUR","IE00BGHQF631.EUR","LU2471134796.USD","LU2602419157.SGD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU2430703251.USD","LU1066051811.HKD","LU0162691827.USD","LU2505996681.GBP","BK4533","LU1066051225.USD","LU1221951046.USD","LU1043141123.HKD","BMED","LU1291159041.SGD","LU0072461881.USD","IE00BZ1G4Q59.USD","IYH","LU2347655156.SGD","LU0820562030.AUD","LU1244550494.USD","LU1228905540.USD","IE0001KFT4U8.USD","LU0426417589.USD","LU2468319806.SGD","LU0210528500.USD","LU0795875086.SGD","LU1894683264.USD","IE00BFXG1179.USD","LU0985320562.USD","BK4559","LU1145028129.USD","LU0466842654.USD","LU1914381329.SGD","LU1496350502.SGD","BK4550","LU1718418525.SGD","IE00BBT3K403.USD","LU2756315318.SGD","IE00BVYPNV92.GBP","LU0070217475.USD","LU1778281490.HKD","JNJ","LU0426412945.USD","LU1983299246.USD","LU1032955483.USD","LU1032466523.USD","LU1196500208.SGD","IE0034235303.USD","BK4007","LU0964807845.USD","LU2129689514.USD","LU1430594728.SGD","LU0511384066.AUD","LU2112291526.USD","LU1228905037.USD","LU1506573853.SGD","LU0234572021.USD","LU1989771016.USD","LU0098860793.USD","LU0289961442.SGD","LU0545562505.USD","LU0683600562.USD","IE00B4R5TH58.HKD","LU1267930813.SGD","LU1674673691.USD","LU0820561909.HKD","LU1074936037.SGD","BK4534","IE00B1BXHZ80.USD","IE000WAW04H5.SGD","IE00BLSP4452.SGD","IE00BFTCPJ56.SGD","LU0472753341.HKD","IE0002141913.USD","LU0234570918.USD","LU0203345920.USD","BK4588","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667902606","title":"強生試驗性抑鬱症藥物未達中期研究主要目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2667902606","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667902606?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 10:25","pubTimestamp":1789439104,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["FHLC","GDOC","LU0069063385.USD","LU0345769128.USD","LU2129689605.HKD","LU1732799900.SGD","MEDX","LU0057025933.USD","XLV","LU0426412945.USD","LU2133065610.SGD","JNJ","BK4007","LU1244550494.USD","SG9999001176.SGD","LU2430703251.USD","IXJ","LU1280957306.USD","VHT","TRUH","IE000MB6IJN5.SGD","BMED","RXL","PJP","IYH","IHE","FTXH","LU0098860793.USD","LU1935042991.SGD","LU0432979614.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD","LU0689626769.HKD","IE00BN8TJ469.HKD","IE00BLSP4239.USD","JDOC","LU2430703178.SGD","LU0058720904.USD","LU1914381329.SGD","LU1674673691.USD","LU0210536198.USD","LU0820561818.USD","LU2471134796.USD","LU0689472784.USD","LU0964807845.USD","LU1066051225.USD","SG9999002232.USD","IE000BZT7R73.USD","LU0683600562.USD","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667022693","title":"Contineum與強生合作的抑鬱症藥物未能達到中期試驗目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2667022693","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667022693?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 04:11","pubTimestamp":1789416695,"startTime":"0","endTime":"0","summary":"Contineum与强生合作的抑郁症药物未能达到中期试验目标路透9月14日-Contineum Therapeutics（CTNM.O）周一表示，该公司与强生公司（JNJ.N）联合研发的一种抗抑郁试验性药物未能达到中期临床试验的主要目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4T4561IQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","IXJ","LU0683600562.USD","LU1066051225.USD","LU0345769128.USD","LU0058720904.USD","LU1267930813.SGD","JDOC","FHLC","SG9999001176.SGD","LU1043141123.HKD","LU2430703095.HKD","PJP","JNJ","IYH","LU0912757837.SGD","LU2602419157.SGD","LU2471134523.USD","GDOC","LU0345770308.USD","BK4532","VHT","FTXH","LU2592432038.USD","BK4504","IHE","LU1066051811.HKD","LU1221951129.SGD","LU0203347892.USD","BK4568","IE00BLSP4452.SGD","BMED","IE0002270589.USD","LU0289739699.SGD","IE00BZ1G4Q59.USD","IE00B4R5TH58.HKD","LU0289739343.SGD","IE00BBT3K403.USD","LU0792757196.USD","IE000WAW04H5.SGD","XLV","LU2417539215.USD","MEDX","LU1162221912.USD","TRUH","RXL","IE00BLSP4239.USD","IE00B3PB1722.GBP","LU1291159041.SGD","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154472655","title":"默沙東高管：上調700億美元業績預測的時機「尚待確定」 但「勢在必行」","url":"https://stock-news.laohu8.com/highlight/detail?id=1154472655","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154472655?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 03:49","pubTimestamp":1789415350,"startTime":"0","endTime":"0","summary":"默沙东高层放话——那份高达700亿美元的财务预测，上调时机眼下“仍有待商榷”，可话音未落，又补了一句：该来的，总会来。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772840.SGD","LU2491050071.SGD","LU0965509283.SGD","IE0009355771.USD","SG9999013999.USD","LU2361044865.SGD","LU0477156953.USD","LU0289739699.SGD","LU0511384066.AUD","LU2023250504.SGD","LU0208291251.USD","LU0942090050.USD","IXJ","LU1162221912.USD","IE00BN8TJ469.HKD","TRUH","LU1066051498.USD","SG9999014575.USD","LU0234572021.USD","SG9999015358.SGD","LU1929549753.HKD","SG9999002224.SGD","LU0859254822.USD","LU1934455277.USD","PAWZ","LU0098860793.USD","LU0058720904.USD","LU0238689110.USD","LU1035773651.USD","LU0965508806.USD","LU1934455194.USD","LU1571399168.USD","LU1989772923.USD","LU2112291526.USD","LU2461242641.AUD","LU2361045086.USD","LU0265550946.USD","BK4516","LU0106261372.USD","SG9999001440.SGD","LU1201861249.SGD","LU0266013472.USD","LU1116320737.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","LU2023250843.SGD","LU1923622614.USD","RXL","LU1917777945.USD","LU0861579265.USD","LU1585245621.USD","LU0211331839.USD","LU1061106388.HKD","BK4559","IE00BFTCPJ56.SGD","LU0432979614.USD","LU0057025933.USD","SG9999015341.SGD","SG9999014567.USD","IYH","LU1291159041.SGD","FTXH","LU1934455863.HKD","LU0868494617.USD","LU1941712348.USD","LU2125154778.USD","LU0130517989.USD","LU1066051225.USD","LU0122379950.USD","LU1037948897.HKD","LU0289961442.SGD","IE00BLSP4452.SGD","LU1093756325.SGD","LU1032466523.USD","IHE","LU1989771016.USD","IE00BBT3K403.USD","LU0320765489.SGD","PPH","GDOC","SG9999014542.SGD","LU1057294990.SGD","JDOC","SG9999002232.USD","XLV","IE000M9KFDE8.USD","LU0070302665.USD","LU0868494708.USD","HRTS","LU2491049909.HKD","BK4533","BK4007","IE00BSNM7G36.USD","LU1983299246.USD","LU1116320901.HKD","IE0002141913.USD","LU2433249047.HKD","LU1066053197.SGD","LU1941712264.USD","LU0689626769.HKD","LU1066051811.HKD","LU0203347892.USD","LU0965509101.SGD","IE00B4R5TH58.HKD","BK4588","LU0069063385.USD","LU2360032135.SGD","LU1037948541.HKD","LU1093756168.USD","LU0965509010.AUD","LU0980610538.SGD","VHT","LU2089984988.USD","LU2361044949.HKD","BK4550","LU0124676726.USD","SG9999001176.USD","LU2125154935.USD","BMED","LU2357627491.SGD","LU0823416689.USD","LU0006306889.USD","LU1430594728.SGD","BK4534","IE00B1BXHZ80.USD","LU1699723380.USD","LU0648001328.SGD","LU0320765646.SGD","LU0130102774.USD","BK4585","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0265550359.USD","LU0289739343.SGD","LU2106854487.HKD","LU1974910355.USD","LU2125909593.SGD","LU0472753341.HKD","LU0985320562.USD","MRK","SG9999001176.SGD","LU0203345920.USD","LU1069347547.HKD","LU2324357040.USD","SGXZ57979304.SGD","LU2491050154.USD","LU2125909247.SGD","SG9999014559.SGD","LU2468319806.SGD","IE00BLSP4239.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693682","title":"默沙東： 340B 項目及相關政策的潛在變化或將帶來利好，但對業務影響有限。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693682","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693682?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 03:35","pubTimestamp":1789414559,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1934455277.USD","LU2491049909.HKD","LU0965508806.USD","BK4516","LU2023250504.SGD","LU0130517989.USD","LU0289739343.SGD","LU2461242641.AUD","LU2089984988.USD","LU0130102774.USD","LU0265550359.USD","LU1989772923.USD","LU1037948897.HKD","BK4550","LU1291159041.SGD","LU1699723380.USD","LU2125909247.SGD","BK4559","LU0942090050.USD","SG9999001176.SGD","LU1066051811.HKD","BK4534","LU1037948541.HKD","LU0234572021.USD","RXL","GDOC","FHLC","LU2491050071.SGD","LU0980610538.SGD","LU0985320562.USD","LU2112291526.USD","IE00BSNM7G36.USD","LU1934455863.HKD","IE0002141913.USD","BK4007","IE000M9KFDE8.USD","LU0861579265.USD","LU0057025933.USD","LU0070302665.USD","LU2324357040.USD","LU0320765646.SGD","LU2125154778.USD","SG9999001440.SGD","LU1069347547.HKD","LU0006306889.USD","LU2491050154.USD","TRUH","LU1035773651.USD","IE0009355771.USD","LU0122379950.USD","SGXZ57979304.SGD","LU0511384066.AUD","BK4588","IE00BN8TJ469.HKD","IXJ","HRTS","IE00B4R5TH58.HKD","JDOC","LU1923622614.USD","LU2357627491.SGD","IE00BJJMRZ35.SGD","SG9999014575.USD","LU0203347892.USD","SG9999001176.USD","SG9999002224.SGD","LU1066051498.USD","LU1941712348.USD","LU2468319806.SGD","LU1093756325.SGD","IE00BJT1NW94.SGD","LU1974910355.USD","SG9999002232.USD","SG9999013999.USD","IE00BLSP4452.SGD","SG9999014559.SGD","XLV","LU0211331839.USD","LU0289739699.SGD","LU1023059063.AUD","IYH","LU0265550946.USD","LU0965509101.SGD","LU1057294990.SGD","LU2125154935.USD","LU1934455194.USD","SG9999015358.SGD","LU0289961442.SGD","LU0203345920.USD","SG9999014542.SGD","LU1917777945.USD","LU1061106388.HKD","IE00B2B36J28.USD","FTXH","LU0648001328.SGD","LU0859254822.USD","LU2106854487.HKD","LU1983299246.USD","BMED","LU1066053197.SGD","LU1585245621.USD","LU0208291251.USD","LU0868494617.USD","LU0472753341.HKD","LU0124676726.USD","BK4585","LU0058720904.USD","LU1066051225.USD","LU1941712264.USD","IHE","LU0432979614.USD","SG9999014567.USD","LU0965509283.SGD","LU0266013472.USD","LU2361044865.SGD","VHT","LU2360032135.SGD","LU2361044949.HKD","PAWZ","PPH","SG9999015341.SGD","IE00BBT3K403.USD","LU1032466523.USD","IE00BLSP4239.USD","LU0106261372.USD","IE00B1BXHZ80.USD","LU2023250843.SGD","LU1430594728.SGD","LU0965509010.AUD","IE00BFTCPJ56.SGD","LU0320765489.SGD","LU1093756168.USD","LU1929549753.HKD","BK4533","LU0689626769.HKD","LU1989772840.SGD","LU1162221912.USD","LU0069063385.USD","LU0238689110.USD","LU1116320901.HKD","LU1571399168.USD","LU1116320737.USD","LU1989771016.USD","LU1201861249.SGD","LU2125909593.SGD","LU0823416689.USD","LU0477156953.USD","LU2361045086.USD","LU2433249047.HKD","LU0868494708.USD","MRK","LU0098860793.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152640685","title":"默沙東高管：340B政策與政策演變或成順風因素，但對業務無實質性影響——摩根士丹利會議紀要","url":"https://stock-news.laohu8.com/highlight/detail?id=1152640685","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152640685?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 03:34","pubTimestamp":1789414476,"startTime":"0","endTime":"0","summary":"默沙东高管在摩根士丹利会议上表示，虽然340B药品折扣计划及政策环境的变化可能为公司带来一定的积极因素，但总体而言，这些变动并不构成对业务的实质性影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JDOC","BK4007","LU1093756168.USD","IE00B1BXHZ80.USD","LU2461242641.AUD","SG9999001176.USD","IHE","LU0477156953.USD","SG9999002224.SGD","LU0265550946.USD","LU0266013472.USD","SG9999001440.SGD","IXJ","SG9999014575.USD","LU0980610538.SGD","LU1066053197.SGD","LU2125909247.SGD","LU1585245621.USD","LU0238689110.USD","LU0823416689.USD","BK4559","IE00B2B36J28.USD","LU1116320737.USD","LU0203347892.USD","LU0211331839.USD","LU1032466523.USD","IE00BLSP4452.SGD","LU0985320562.USD","LU2125154935.USD","LU0511384066.AUD","LU2491050071.SGD","LU1066051811.HKD","LU0289739699.SGD","LU1066051498.USD","LU2433249047.HKD","LU1941712348.USD","BK4585","BMED","IE00BJJMRZ35.SGD","PAWZ","VHT","LU0689626769.HKD","IE00BLSP4239.USD","LU1430594728.SGD","IE0002141913.USD","LU1934455194.USD","LU1201861249.SGD","IE000M9KFDE8.USD","LU0203345920.USD","FHLC","LU1699723380.USD","LU1035773651.USD","LU0070302665.USD","LU0124676726.USD","FTXH","LU1989771016.USD","LU0432979614.USD","BK4588","LU1983299246.USD","LU0289961442.SGD","SG9999015341.SGD","IYH","LU1989772840.SGD","LU2125909593.SGD","SG9999013999.USD","SGXZ57979304.SGD","LU0868494708.USD","LU0006306889.USD","IE00BN8TJ469.HKD","LU1037948897.HKD","LU1116320901.HKD","LU2023250843.SGD","RXL","MRK","LU0942090050.USD","LU2361044949.HKD","LU1061106388.HKD","LU2361045086.USD","IE0009355771.USD","LU0320765489.SGD","LU1057294990.SGD","LU0648001328.SGD","LU0965509010.AUD","LU2360032135.SGD","LU0965509101.SGD","LU0130517989.USD","LU1066051225.USD","LU2468319806.SGD","LU1929549753.HKD","LU1037948541.HKD","LU0098860793.USD","LU1291159041.SGD","LU0861579265.USD","LU1974910355.USD","LU0130102774.USD","LU0868494617.USD","LU1941712264.USD","LU0265550359.USD","LU0058720904.USD","LU0320765646.SGD","IE00BJT1NW94.SGD","LU1989772923.USD","LU1923622614.USD","GDOC","LU2357627491.SGD","LU2361044865.SGD","LU1093756325.SGD","BK4534","LU2324357040.USD","LU1934455277.USD","LU1069347547.HKD","HRTS","LU0057025933.USD","SG9999014559.SGD","LU0965509283.SGD","LU0289739343.SGD","IE00BFTCPJ56.SGD","SG9999001176.SGD","LU2106854487.HKD","SG9999014542.SGD","LU0208291251.USD","LU2112291526.USD","BK4550","LU0234572021.USD","LU1934455863.HKD","LU1023059063.AUD","BK4516","LU2023250504.SGD","SG9999002232.USD","LU0859254822.USD","LU1917777945.USD","PPH","TRUH","XLV","LU2125154778.USD","LU2491050154.USD","LU0122379950.USD","LU2491049909.HKD","LU2089984988.USD","LU1571399168.USD","BK4533","SG9999014567.USD","LU1162221912.USD","IE00B4R5TH58.HKD","IE00BSNM7G36.USD","IE00BBT3K403.USD","LU0965508806.USD","LU0472753341.HKD","LU0106261372.USD","SG9999015358.SGD","LU0069063385.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667966615","title":"BUZZ——美國股市動態-美國能源股、鮑德温、強生","url":"https://stock-news.laohu8.com/highlight/detail?id=2667966615","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667966615?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 20:46","pubTimestamp":1789389982,"startTime":"0","endTime":"0","summary":"BUZZ——美国股市动态-美国能源股、鲍德温、强生工作区中用于查询单只股票行情的搜索字符串：STXBZ《今日展望》通讯：https://refini.tv/3LI4BU7《晨间新闻简报》：https://refini.tv/3dKUyB8路透9月14日-周一早盘，追踪纳斯达克100指数的期货领跌，受人工智能（AI）权重股抛售拖累，此前美国多位高管以安全担忧为由，呼吁放缓人工智能技术的发展。.N**","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4T4560YF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1003077747.HKD","LU0265550946.USD","ERX","IE00B42XCP33.USD","SNVDAmain","AMUU","BK4515","LU1261432733.SGD","IE00BJJMRX11.SGD","SG9999014880.SGD","IE0000B7K699.USD","LU0029864427.USD","LU1582986359.USD","LU0162691827.USD","NEM","SG9999015952.SGD","NVDG","LU0823434740.USD","LU1066053197.SGD","LU1720051108.HKD","LU1989764748.USD","BK4554","DAMD","LU1069344957.HKD","LU2463028550.USD","LU1116320901.HKD","LU2471134796.USD","BK4503","FTXN","LU0256863902.USD","AMYY","LU2394011477.USD","IE0004091025.USD","SG9999015978.USD","IGE","IE00B19Z3581.USD","CHPS","LU1291159041.SGD","LU2047632596.USD","LU2360032135.SGD","BK4529","IE00BFSS7M15.SGD","TEK","LU0354030511.USD","LU1066051225.USD","LU1162221912.USD","LU1228905037.USD","LU2347655073.USD","LU0985320562.USD","LU0211328371.USD","BK4566","LU0098860793.USD","LU0308772762.SGD","SG9999015945.SGD","LU2112291526.USD","IE00BJTD4V19.USD","SNPE","THMR","LU1032466523.USD","LU1400636491.USD","LU2417539215.USD","LU0079474960.USD","FDTX","BK4598","LU0345768153.USD","LU1150488135.SGD","LU1815336760.USD","WUGI","LU1868838027.USD","IE00BMPRXR70.SGD","IE0004445015.USD","LU0390134368.USD","LU2357305700.SGD","SG9999014567.USD","LU0114720955.EUR","LU1150488218.USD","LU0006306889.USD","LU0170899867.USD","LU2272731600.USD","AIQ","LU0494093205.USD","LU2271345857.HKD","LU2462157665.USD","LU2506951792.HKD","BK4551","FTXH","LU1400636657.SGD","BK4543","LU0345780950.USD","LU0267386448.USD","LU1119994496.HKD","LU1489326972.SGD","LU1814569148.SGD","LU0823414478.USD","IBRN","LU2720916845.USD","LU0795875169.SGD","LU0106261372.USD","LU0069063385.USD","LU0238689110.USD","LU1221951046.USD","LU1868837565.USD","LEGR","XOMX","TYLG","IE00BFXG1179.USD","LU0942090050.USD","VGT","IE0005OL40V9.USD","LU1221951129.SGD","LU1718418525.SGD","LU1983260115.SGD","LU0198837287.USD","LU2089985449.USD","BK4213","LU1430597077.USD","IE00B3S45H60.SGD","LU0276348264.USD","LU0130103400.USD","LU0786609619.USD","VHT","LU0788109477.HKD","AU","LU0353189680.USD","LU1917777945.USD","LU2361044865.SGD","IE0009355771.USD","LU2089984988.USD","LU0820561909.HKD","LU2403377893.USD","LU0788109121.HKD","SG9999001176.USD","LU2237443382.USD","IE00B2B36J28.USD","BK4173","IE00B19Z3B42.SGD","IE00BJLML261.HKD","LU2244417387.USD","SG9999014542.SGD","LU0096364046.USD","MRVL","IE000W1ABFV2.USD","HK0000320223.HKD","THNR","IE00B3CCJ963.GBP","LU0965509101.SGD","BK4585","LU1032955483.USD","LU2999663052.SGD","IE00BJTD4N35.SGD","04335","LU2361044949.HKD","LU1934455863.HKD","IE00BMPRXN33.USD","LU0109392836.USD","LU0127658192.USD","LU2065171402.SGD","LU1223083913.SGD","LU2065170008.USD","LU0630314457.HKD","TTEQ","LU2125154778.USD","LU1202635105.USD","LU2237443465.HKD","SG9999002521.SGD","AMDD","LU2452424414.USD","LU0266512127.USD","AUMI","ESUM","LU0048573561.USD","LU0133085943.USD","LU1923623000.USD","LU2097344431.USD","LU0661504455.SGD","NVII","LU0742534661.SGD","LU0158827948.USD","TRUM","IE000BZT7R73.USD","BK4535","IYH","IE00BQXX3F31.USD","SG9999018865.SGD","LU2458330243.SGD","GOAU","LU2413666699.HKD","USXF","IE000SO60NU8.SGD","HK0000304797.USD","LU0345770993.USD","LU2290526834.HKD","SG9999015341.SGD","FTEC","LU2430703251.USD","HK0000306685.HKD","LU2168564149.EUR","BK4549","LU0056508442.USD","LU2552382058.USD","IE00BSNM7G36.USD","LU0912757837.SGD","LU0823434583.USD","FCG","LU0068578508.USD","TEXU","LU1551013342.USD","LU0300736062.USD","LU1935042991.SGD","LU1232071149.USD","LU1839511570.USD","LU0225283273.USD","NVDL","LU2286300806.USD","LU0061475181.USD","IE00BZ199S13.USD","IE0002141913.USD","LU0251131958.USD","LU0683600562.USD","LU2764263203.CNY","LU0472753341.HKD","HK0000819398.USD","LU0861579265.USD","IE000YTNTUN2.SGD","LU2236285917.USD","LU0612318971.USD","LU0792757196.USD","ILDR","AMD","LU0157215616.USD","BWIN","LU2213496289.HKD","LU2357125470.USD","LU1868836757.USD","MVLL","LU0889565833.HKD","LU2430703178.SGD","LU1244550221.USD","LU2237438978.USD","LU1861558580.USD","LU1435385759.SGD","LU2552382215.SGD","LU0072461881.USD","LU0985489474.SGD","LU2860962120.EUR","LU1914381329.SGD","LU2108987350.USD","BK4604","LU1894683264.USD","LU0348723411.USD","IE00B775SV38.USD","NEMG","HK0000306701.USD","LU0965509283.SGD","BK4568","SGXZ51526630.SGD","SRRK","DIPS","LU1868836591.USD","LU1037948897.HKD","LU0130517989.USD","HK0000532082.HKD","LU0882574139.USD","LU0094547139.USD","LU0889566641.SGD","09788","LU0128525929.USD","LU1821325948.USD","LU2242649171.HKD","JDOC","LU0980610538.SGD","LU0689626769.HKD","LU1366333091.USD","DRLL","LU0345780521.USD","LU1674673691.USD","LU1923622291.USD","LU2023251221.USD","IE00BN29S564.USD","LU2191332357.HKD","LU0251132253.USD","HK0000914660.USD","LU1235294995.USD","LU1145028129.USD","NVDD","LU0795875086.SGD","LU0130102774.USD","LU1223082519.USD","HK0000304805.HKD","XOMZ","GXPE","LU0345780281.USD","BK4161","LU0070302665.USD","SINTCmain","TRUH","LU0278409577.USD","HK0000320264.USD","LU1989772923.USD","IE00BWXC8680.SGD","IE00BK4W5L77.USD","LU1935042215.USD","IE000WAW04H5.SGD","IE00BKVL7J92.USD","NVC","LU0820561818.USD","LU0321505868.SGD","IE00BD6J9T35.USD","LU1429558221.USD","LU0787776722.HKD","IE00BMPRXQ63.HKD","LU2237443622.USD","XOMO","LU0143863198.USD","LU0345769128.USD","IE00BHPRN162.USD","LU2360106780.USD","TTXU","IE00B1XK9C88.USD","LU0158827781.USD","LU1699723380.USD","LU2746668974.SGD","TRUN","LU2125909916.SGD","PJP","BK4570","INTW","LU2237443895.HKD","SLVP","LU0426417589.USD","SMHX","LU1880398554.USD","LU0648001328.SGD","IE00B775H168.HKD","SGXZ31699556.SGD","CMAG","NVDQ","COP","CNEQ","HK0000914686.HKD","IE000Q6AESB8.SGD","LU1645745479.HKD","LU2746668461.USD","LU0203345920.USD","LU1883866441.USD","LU2237443549.SGD","LU0124676726.USD","LU0082616367.USD","LU0215105999.USD","IE00BYXW3230.USD","LU0466842654.USD","LU0868494708.USD","LU2764263039.SGD","LU0342679015.USD","LU1116320737.USD","LU0310799852.SGD","LU0320765489.SGD","LU1169589451.USD","VDE","BK4532","IETC","EFIV","FHLC","LU1069347547.HKD","LU2065171311.SGD","LU0320765059.SGD","07388","LU1935042488.USD","LU2361045086.USD","IE0034235188.USD","LU0994945656.USD","LU0878866978.SGD","NVDY","AMDW","MEDX","SOXQ","LU1712237335.SGD","LU0289960550.SGD","IEO","LU2430703095.HKD","CRBP","DIG","NVIW.SI","LU2237957811.SGD","SG9999001440.SGD","LU2023250330.USD","LU0432979614.USD","LU2326559502.SGD","LU2089283258.USD","IXN","2NVD.UK","LU2272731865.HKD","LU2237957902.USD","LU0208291251.USD","LU1633808545.USD","SG9999014575.USD","LU2637965513.SGD","IE00BFTCPJ56.SGD","LU0648000940.SGD","LU0368265418.SGD","IE00BDGV0183.EUR","LU0823421333.USD","BK4141","DRIV","IE000M9KFDE8.USD","LU1127390331.HKD","LU2272731782.SGD","NVDU","LU0154236417.USD","LU0642271901.SGD","LU0303823156.USD","LU2413666426.HKD","LU2168564222.USD","LU0203347892.USD","LU0266013472.USD","LU1303367103.USD","LU1496350171.SGD","IE0002270589.USD","LU1923622614.USD","LU0143863784.USD","BK4567","LU0957808578.USD","LU2471134523.USD","LU1732800096.USD","LU1868836914.USD","CVX","LU1623119135.USD","LU1244550494.USD","LU1791710400.SGD","LU2462591350.SGD","LFGY","07788","LU1043141123.HKD","LU2462611646.USD","LU2931357623.SGD","LU1951200564.SGD","LU0823421416.USD","LU2054465674.USD","LU2211815571.USD","IE0034235295.USD","LU0511384066.AUD","QQQA","GB00BDT5M118.USD","LU1242518931.SGD","LU1989771016.USD","LU1102505762.USD","CLSE","BK4614","IE00B3PB1722.GBP","LU1144417596.USD","LU0314106906.USD","LU1852331112.SGD","LU1992135472.HKD","AMDY","IE0034235303.USD","LU2168564065.EUR","SGXZ23171101.USD","LU2129689605.HKD","CHPX","LU2097344357.USD","BK4559","LU0310800379.SGD","IE00BJT1NW94.SGD","MRVX","LU2092627202.USD","NVYY","LU0724617625.USD","LU0187121727.USD","LU0289739343.SGD","ESLG","LU0553294199.USD","LU0640476718.USD","JNJ","IE00B3M56506.USD","LU1066051498.USD","LU0719512351.SGD","SG9999004303.SGD","LU1989764664.SGD","ARTY","LU1061106388.HKD","LU0433182093.SGD","RUM","SOXY","LU2322448957.HKD","GFI","LU0256863811.USD","BK4512","GDX","JGRO","LU1815333072.USD","METV","LU0109391861.USD","ROM","LU1074936037.SGD","LU1791710582.SGD","LU0011850046.USD","LU0138981039.USD","LU0203201768.USD","LU2750360997.AUD","LU2125909759.SGD","AMDU","AFK","BK4592","LU1868837300.USD","LU2347655156.SGD","PSI","LU0070217475.USD","IE00BDRTCR15.USD","BK4522","IE00BKPKM429.USD","AIFD","LU1057294990.SGD","SPTE","IE00B19Z8W00.USD","LU1035773651.USD","LU0265550359.USD","LU0149725797.USD","LU0323239441.USD","AMDC","RXL","SGXZ57979304.SGD","IE00BZ1G4Q59.USD","AMDG","IE00B19Z9505.USD","LU2433249047.HKD","LU2360107168.USD","LU2473716301.USD","SG9999018857.SGD","BK4077","LU1267930573.SGD","LU1983299246.USD","LU2543165471.USD","INYY","NVD","LU1316542783.SGD","BK4579","LU2237443978.SGD","LU2264538146.SGD","LU2756315664.SGD","CHAT","09388","AIS","LU2106854487.HKD","SG9999014898.SGD","DTCR","LU1674673428.USD","LU1732799900.SGD","IE00B3T34201.USD","IE0003U64NQ7.SGD","IE00B5949003.HKD","LU0107464264.USD","LU1721428933.USD","IE00BFSS8Q28.SGD","LU0976567544.SGD","LU0345770308.USD","BK4534","LU0057025933.USD","LU1861215975.USD","LU2063271972.USD","SG9999015986.USD","LU2896262040.SGD","SG9999014906.USD","LU1102505929.USD","BK4201","LU0545039389.USD","LU0097036916.USD","IE00B19Z8X17.USD","LU2592432038.USD","SG9999002224.SGD","LU0316494557.USD","AMDS","BK4605","LU2102340556.USD","IE00B1BXHZ80.USD","IE00BGHQF524.EUR","LU0353189763.USD","LU0321505439.SGD","SGXZ81514606.USD","LU0898699433.AUD","LU0456854461.SGD","LU0096362180.USD","LU0612318385.USD","LU1267930813.SGD","SOXX","SGXZ99366536.SGD","LU1880398471.USD","LU0368265764.SGD","LU1571399168.USD","LU0965509010.AUD","LU2355687059.USD","NVDO","LU1023059063.AUD","LU1642822529.SGD","IXJ","LU0234570918.USD","LU2129689431.USD","LU2250418816.HKD","BK4017","IE0009G5SDU7.USD","LU0724618789.USD","LU0545562505.USD","LU1894683348.USD","FXL","LU1548497426.USD","LU0058720904.USD","LU0444971666.USD","LU2498475776.HKD","LU1935043023.USD","BK4612","LU0395794307.EUR","IE0009356076.USD","LU0426412945.USD","LU2089284900.SGD","AMDL","LU2242650005.HKD","GAMR","LU2420271590.USD","NVDA","LU2111349929.HKD","LU0964807845.USD","LU0310800965.SGD","LU1551013425.SGD","LU2125909247.SGD","BK4548","IE00BQXX3D17.EUR","LU1121112475.USD","AGOX","LU1935043536.SGD","BK4007","IHE","BAI","BK4573","LU0211327993.USD","LU0859254822.USD","LU1804176565.USD","LU0354030438.USD","BK4550","LU1992135399.USD","LU2129689514.USD","LU0080751232.USD","LU0274383776.USD","LU0122376428.USD","ELMT","LU0957791311.USD","IE00B4JS1V06.HKD","LU1506573853.SGD","IE00BLSP4239.USD","LU0175139822.USD","IE00BLSP4452.SGD","LU2458330169.SGD","LU1934455277.USD","LU0300736492.USD","LU2462591277.SGD","MRVU","XLK","LU0708995401.HKD","IE000ITXATA3.USD","LU1582986433.USD","LU1691799644.USD","IE00BQXX3C00.GBP","LU0496367417.USD","LU1228905540.USD","WISE","BK4588","LU1496350502.SGD","LU1366192091.USD","LU0075056555.USD","FAI","VT","IE00B2Q91V27.USD","EOG","LU1066051811.HKD","LU2471134952.CNY","LU1929549753.HKD","LU0979878070.USD","LU0061474705.USD","LU0689472784.USD","SG9999017495.SGD","AUAU","LU0289739699.SGD","LU0266512473.USD","LU1196500208.SGD","INT","LU2098885051.SGD","INTC","LU1267930730.SGD","LU2249611893.SGD","IE00BN8TJ469.HKD","LU0053666078.USD","LU2125154935.USD","SG9999014559.SGD","NVDW","IE00BJJMRY28.SGD","LU0868494617.USD","LU1023059493.AUD","LU1400636574.HKD","LU1084165304.USD","LU2133065610.SGD","LU1223082196.USD","IE00BVYPNW00.USD","LU0528227936.USD","XNTK","LU1323610961.USD","LU1629891620.HKD","LU2322448791.USD","LU1585245621.USD","LU2756315318.SGD","IE000KEQY171.SGD","LU0174119429.USD","NULC","SG9999001424.SGD","GDOC","LU3102509885.SGD","IE00BDCRKT87.USD","LU1951198990.SGD","NVDX","LU0557290698.USD","BK4139","LU0289961442.SGD","FENY","LU0823414551.USD","LU0210536198.USD","LU0052756011.USD","LU2023250504.SGD","XLE","FMTL","LU0820562030.AUD","LU0672654240.SGD","LU2092937148.SGD","IXC","LU0726765562.USD","LU1430594728.SGD","BK4575","LU2750360641.GBP","FTXL","NVD2.UK","IE0004445239.USD","LU2125909593.SGD","IE000F7OJYX1.SGD","LU2764262908.HKD","LU0323591593.USD","OILT","LU2357627491.SGD","BK4581","SG9999013999.USD","LU1935043452.HKD","LU0708994859.HKD","LU0943347566.SGD","LU2247934214.USD","NWMX","LU1861220033.SGD","BK4602","SG9999014914.USD","LU0234572021.USD","LU0128525689.USD","LU0323240290.USD","NVDS","XOM","ABFL","LU0210533765.USD","LU1861127337.USD","LU2168564495.EUR","LU2294711713.HKD","LU1059921491.USD","LU0345768740.USD","GDMN","SG9999002232.USD","LU0143551892.USD","GLDN","LU1201861249.SGD","LU1280957306.USD","LU2028103732.USD","LU1201861165.SGD","SG9999001176.SGD","LU0203202063.USD","LU0965508806.USD","LU2491049909.HKD","USD","LU2381873111.SGD","LU2505996509.AUD","LU1153585028.USD","BK4587","LU2168563687.JPY","LU2505996681.GBP","IE00BJJMRZ35.SGD","LU1988902786.USD","SG9999015358.SGD","SMH","LU2065169927.USD","IE00BGHQF631.EUR","LU0476273544.USD","3NVD.UK","SG9999000418.SGD","LU0417517546.SGD","LU0330918003.SGD","LU2279689827.SGD","IE00B5TLWC47.USD","LU2491050154.USD","LU1670756490.USD","IE00B4YYXB79.USD","LU2077746001.SGD","LU0210528500.USD","LU2468319806.SGD","LU0048584097.USD","LU0496365809.HKD","NVDB","TRFK","XLV","SNVD.UK","NVDS.UK","LU0788108826.HKD","LU1861559042.SGD","LU2100268510.USD","BK4608","IE00BVYPNV92.GBP","LU1803068979.SGD","LU1934455194.USD","IE00BKDWB100.SGD","LU0077335932.USD","BK4516","HMY","IYE","LU1043141396.HKD","LU0738911758.USD","LU0347712357.USD","LU0498741114.HKD","LU1242518857.USD","LU1979441026.SGD","LU2456880835.USD","LU2552382132.HKD","LU0211326755.USD","BK4527","WEEI","LU0345769631.USD","LU1989772840.SGD","LU0444973449.USD","IE00B7SZLL34.SGD","GTEK","AGMI","LU0320765646.SGD","LU0122379950.USD","LU1267930227.SGD","LU2265009873.SGD","AIPI","LU2487616109.SGD","SHOC","LU0882574055.USD","SGDM","LU0256331488.USD","LU1037948541.HKD","IE0001KFT4U8.USD","LU1035775433.USD","LU1064131342.USD","LU1244550577.SGD","LU1720051017.SGD","LU1823568750.SGD","CNAV","LU1974910355.USD","LU2461242641.AUD","LU1778281490.HKD","LU0072462426.USD","LU1267930490.SGD","LU1582987324.SGD","LU0345781412.USD","LU1868837136.USD","IE000MB6IJN5.SGD","LU0055631609.USD","LU0788109394.HKD","BK4504","LU0081259029.USD","LU0211326839.USD","LU0654597011.USD","LU1169590202.USD","IE00BBT3K403.USD","LU2087621335.USD","LU0303821028.USD","NVD3.UK","LU0251142724.SGD","LU2602419157.SGD","SAMD0main","LU0949170772.SGD","LU2087625088.SGD","LU2148611432.USD","SG9999001143.SGD","PXE","LU1582987597.SGD","LU2491050071.SGD","ANV","IE00B7KXQ091.USD","IE00BK4W5M84.HKD","BK4533","SGXZ80539844.SGD","LU0498741890.SGD","LU2954938101.SGD","IE0004086264.USD","IE00B4R5TH58.HKD","IE00B3SWFQ91.USD","LINT","LU0477156953.USD","BMED","LU2083900584.USD","LU1046421795.USD","LU0061474960.USD","LU2471134879.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667666344","title":"強生表示，在一項非小細胞肺癌研究中，RYBREVANT聯合化療可將死亡風險降低43%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667666344","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667666344?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 20:34","pubTimestamp":1789389267,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BMED","LU2487616109.SGD","LU1244550577.SGD","LU0072461881.USD","IE00BZ1G4Q59.USD","LU0345769631.USD","TRUH","LU1506573853.SGD","BK4581","IE00B1BXHZ80.USD","BK4585","MEDX","LU2129689514.USD","LU1221951129.SGD","LU2129689605.HKD","IHE","GDOC","LU0820561818.USD","IE000BZT7R73.USD","JDOC","LU2471134952.CNY","LU0985320562.USD","IE00BFXG1179.USD","LU0203347892.USD","LU0098860793.USD","LU0162691827.USD","BK4592","LU0234572021.USD","FTXH","LU0964807845.USD","VHT","PJP","LU0069063385.USD","RXL","SG9999013999.USD","JNJ","IYH","LU0994945656.USD","LU0787776722.HKD","IXJ","LU1551013425.SGD","LU1074936037.SGD","XLV","LU1032466523.USD","FHLC","LU0203345920.USD","LU0122379950.USD","LU0426412945.USD","IE0002270589.USD","SG9999001176.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123296647","title":"強生Rybrevant®聯合化療在EGFR外顯子20插入突變陽性肺癌中展現迄今最長中位總生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=1123296647","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123296647?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 20:34","pubTimestamp":1789389249,"startTime":"0","endTime":"0","summary":"强生公司宣布，其研发的Rybrevant®（Amivantamab-Vmjw）联合化疗方案，在治疗EGFR外显子20插入突变阳性的肺癌患者中，取得了迄今报告中最长的中位总生存期。\n这一突破性成果，标志着针对这一特定突变类型肺癌的治疗策略迈上了新的台阶。数据表明，该联合疗法不仅显著延长了患者的生存时间，更在临床上确立了新的疗效标杆。\n值得注意的是，这一结果在同类研究中脱颖而出，为那些携带罕见EGFR突变的患者群体带来了前所未有的希望。强生公司表示，这一疗法有望重新定义肺癌治疗的标准，后续详细数据将在学术会议上公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000BZT7R73.USD","LU0210528500.USD","LU1929549753.HKD","BK4533","LU1057294990.SGD","LU1244550577.SGD","FHLC","IE00BLSP4452.SGD","LU2133065610.SGD","LU2471134796.USD","XLV","LU1629891620.HKD","IE000SO60NU8.SGD","BK4585","IE00B19Z3B42.SGD","IE00BBT3K403.USD","PJP","LU0787776722.HKD","LU0683600562.USD","LU0994945656.USD","IE00BGHQF631.EUR","LU1674673428.USD","LU2430703095.HKD","JNJ","LU1989771016.USD","LU0122379950.USD","SGXZ57979304.SGD","BK4581","LU0057025933.USD","IE0001KFT4U8.USD","LU1430594728.SGD","LU1914381329.SGD","LU2505996509.AUD","IE00B1BXHZ80.USD","LU0072461881.USD","LU0124676726.USD","LU2403377893.USD","LU0820561909.HKD","LU0426412945.USD","IE00BFXG1179.USD","LU0912757837.SGD","LU2896262040.SGD","IE00B3PB1722.GBP","LU1043141123.HKD","LU1145028129.USD","LU0792757196.USD","IE0000B7K699.USD","LU1551013342.USD","LU0058720904.USD","SGXZ80539844.SGD","BK4592","IE00B3T34201.USD","IE00BJT1NW94.SGD","LU0289961442.SGD","LU2089984988.USD","LU2471134879.HKD","MEDX","IE00BVYPNV92.GBP","LU2129689431.USD","LU0345770993.USD","IE0009355771.USD","JDOC","LU0472753341.HKD","IE00B7SZLL34.SGD","LU2023250330.USD","SG9999001440.SGD","LU2602419157.SGD","LU1066053197.SGD","LU1162221912.USD","BK4007","IE00B4R5TH58.HKD","IE00BN8TJ469.HKD","LU2505996681.GBP","IE00B42XCP33.USD","LU0545562505.USD","LU2417539215.USD","LU0053666078.USD","LU0114720955.EUR","IE00BVYPNW00.USD","LU1228905037.USD","LU0689472784.USD","BK4568","LU1244550221.USD","LU1291159041.SGD","LU2112291526.USD","IE00BLSP4239.USD","LU0210536198.USD","LU2430703178.SGD","SG9999002232.USD","LU1674673691.USD","BMED","IE0002141913.USD","LU0985320562.USD","LU0320765646.SGD","BK4559","IE00BDGV0183.EUR","IE000M9KFDE8.USD","LU0234570918.USD","LU2756315664.SGD","LU0689626769.HKD","LU0345769631.USD","LU1894683264.USD","LU0098860793.USD","LU0795875086.SGD","LU1121112475.USD","IE0002270589.USD","LU1894683348.USD","IE00B2B36J28.USD","LU1066051811.HKD","BK4532","LU2468319806.SGD","LU0466842654.USD","LU1032466523.USD","IE000MB6IJN5.SGD","LU2430703251.USD","BK4534","LU2347655156.SGD","BK4504","LU0820562030.AUD","LU1221951046.USD","LU0203345920.USD","IE00BJJMRZ35.SGD","SG9999013999.USD","IE0034235303.USD","LU0882574055.USD","IE000F7OJYX1.SGD","LU0889566641.SGD","IE00BSNM7G36.USD","LU0795875169.SGD","LU1280957306.USD","LU1983299246.USD","LU2129689514.USD","SG9999001176.USD","LU0432979614.USD","LU2456880835.USD","LU1023059063.AUD","LU0426417589.USD","LU0162691827.USD","LU1935042991.SGD","LU1066051225.USD","LU1732800096.USD","LU0069063385.USD","LU2592432038.USD","BK4550","VHT","LU1267930813.SGD","LU1496350502.SGD","IE000WAW04H5.SGD","LU0345769128.USD","IE00B19Z3581.USD","IXJ","LU2471134952.CNY","LU2750360997.AUD","LU0820561818.USD","IE00BZ1G4Q59.USD","LU1074936037.SGD","RXL","LU2487616109.SGD","LU1196500208.SGD","LU2213496289.HKD","LU0640476718.USD","IYH","LU1043141396.HKD","LU1261432733.SGD","BK4588","IE00BFTCPJ56.SGD","LU0203347892.USD","LU0511384066.AUD","LU0345770308.USD","LU1059921491.USD","LU1061106388.HKD","FTXH","LU0234572021.USD","IE00BKVL7J92.USD","LU1228905540.USD","LU1778281490.HKD","LU1032955483.USD","LU0289739699.SGD","LU2129689605.HKD","LU0289739343.SGD","SG9999001176.SGD","GDOC","TRUH","LU2471134523.USD","LU1244550494.USD","LU2750360641.GBP","LU1585245621.USD","LU1718418525.SGD","SG9999002224.SGD","LU1551013425.SGD","LU2236285917.USD","LU0964807845.USD","LU0943347566.SGD","LU1506573853.SGD","LU1732799900.SGD","LU2756315318.SGD","LU1066051498.USD","LU0070217475.USD","IHE","LU1221951129.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667668268","title":"有報導稱阿波羅正就收購強生公司骨科業務部門進行談判，受此消息提振，強生股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668268","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668268?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:28","pubTimestamp":1789385329,"startTime":"0","endTime":"0","summary":"BUZZ-有报导称阿波罗正就收购强生公司骨科业务部门进行谈判，受此消息提振，强生股价上涨9月14日-** 强生公司（JNJ.N）股价在盘前交易中上涨1.3%，报268.96美元** 据彭博社周五援引消息人士报导，阿波罗全球管理公司（APO.N）正就收购该公司骨科业务部门进行谈判（(link)），该交易估值可能接近200亿美元** 报导称，双方可能在数周内达成协议** 该部门2025年营收达93亿美","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4T4560SI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXL","FHLC","LU2133065610.SGD","IYH","BMED","IE00B3PB1722.GBP","LU2347655156.SGD","JNJ","LU0795875169.SGD","IE000BZT7R73.USD","PRVT","AAUM","LU0124676726.USD","LBO","LU1291159041.SGD","LU1929549753.HKD","IXJ","IE0034235303.USD","GDOC","LU1043141123.HKD","TRUH","BK4135","XLV","LU1791807156.HKD","LU0994945656.USD","IE00BFTCPJ56.SGD","BK4184","APO","PJP","MEDX","LU0098860793.USD","LU0882574055.USD","LU0122379950.USD","LU0943347566.SGD","LU1989771016.USD","IE00BBT3K403.USD","LU2756315664.SGD","SG9999002224.SGD","IE0000B7K699.USD","GPZ","IE00B3T34201.USD","LU0345770308.USD","SG9999013999.USD","IE0009355771.USD","IHE","VHT","LU2430703251.USD","FTXH","JDOC","IE000F7OJYX1.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667668250","title":"有報道稱阿波羅正就收購強生公司骨科業務部門進行談判，受此消息提振，強生股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668250","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668250?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:28","pubTimestamp":1789385329,"startTime":"0","endTime":"0","summary":"BUZZ-有报道称阿波罗正就收购强生公司骨科业务部门进行谈判，受此消息提振，强生股价上涨9月14日-** 强生公司（JNJ.N）股价在盘前交易中上涨1.3%，报268.96美元** 据彭博社周五援引消息人士报道，阿波罗全球管理公司（APO.N）正就收购该公司骨科业务部门进行谈判（(link)），该交易估值可能接近200亿美元** 报道称，双方可能在数周内达成协议** 该部门2025年营收达93亿美","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4S4560SI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPZ","LU1929549753.HKD","IYH","BK4184","IHE","XLV","LU2756315664.SGD","LU0124676726.USD","MEDX","VHT","LU1791807156.HKD","PRVT","FHLC","LU0882574055.USD","AAUM","LU0943347566.SGD","BK4135","IE00BBT3K403.USD","LU2347655156.SGD","IE00B3PB1722.GBP","LU1043141123.HKD","LU0994945656.USD","LU2133065610.SGD","APO","LU0098860793.USD","LU2430703251.USD","PJP","RXL","LU0122379950.USD","IE0009355771.USD","LBO","GDOC","IE00B3T34201.USD","JDOC","LU0345770308.USD","LU0795875169.SGD","IE0034235303.USD","IE000F7OJYX1.SGD","FTXH","IE000BZT7R73.USD","IXJ","SG9999002224.SGD","TRUH","BMED","LU1989771016.USD","SG9999013999.USD","LU1291159041.SGD","IE00BFTCPJ56.SGD","JNJ","IE0000B7K699.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667636436","title":"強生骨科，買家浮出水面","url":"https://stock-news.laohu8.com/highlight/detail?id=2667636436","media":"赛柏蓝器械","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667636436?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:10","pubTimestamp":1789384200,"startTime":"0","endTime":"0","summary":"Apollo盯上强生骨科近期，强生骨科业务剥离有了新进展。不过，这并不意味着强生骨科业务的最终剥离方式已经确定。截至目前，Apollo和强生均未对此事作出回应。自2025年10月公布分拆消息后，历经近一年推进，DePuy Synthes的潜在买家终于浮出水面。强生2025年年报显示，其骨科业务全年销售额为92.58亿美元，约占强生医疗科技收入的27%，同比增长1.1%。从业务表现来看，强生骨科仍处于增长态势。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-14/doc-iniruxuy4555032.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GDOC","IE00B4R5TH58.HKD","LU1929549753.HKD","LU1121112475.USD","LU2023250330.USD","MEDX","LU0072461881.USD","LU1291159041.SGD","LU1221951046.USD","XLV","LU2505996509.AUD","IHE","LU1914381329.SGD","TRUH","LU2430703095.HKD","VHT","BMED","LU0994945656.USD","RXL","JDOC","JNJ","LU1894683348.USD","LU1066053197.SGD","LU1989771016.USD","IE00B1BXHZ80.USD","LU1032955483.USD","SG9999002232.USD","PJP","IE00BSNM7G36.USD","IE000SO60NU8.SGD","FHLC","LU2756315664.SGD","FTXH","LU1196500208.SGD","LU1894683264.USD","IE0009355771.USD","IE00BLSP4452.SGD","LU1674673428.USD","LU1280957306.USD","LU0426412945.USD","IXJ","LU2417539215.USD","SG9999013999.USD","IE00BVYPNW00.USD","LU2236285917.USD","LU0820561818.USD","LU2487616109.SGD","LU2112291526.USD","LU1023059063.AUD","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667668638","title":"博安生物：BA1203獲准開展臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668638","media":"南方财经网","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668638?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:04","pubTimestamp":1789383840,"startTime":"0","endTime":"0","summary":"南财智讯9月14日电，博安生物（06955.HK）发布自愿公告，公司自主研发的在研PD-1/IL-2抗体细胞因子前药BA1203的新药临床试验申请（IND）已获得中国国家药品监督管理局药品审评中心（CDE）批准，拟开发用于多种实体瘤的治疗。BA1203为全球唯一的IL-2α受体高活性、遮蔽型且PD-1阻断型PD-1/IL-2分子。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609143873558977.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609143873558977.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["MDTX","PSYK","IBBQ","IBBJ","BMED","06955","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667657414","title":"康哲藥業(00867)：創新藥高選擇性TYK2抑制劑CMS-D001 獲得系統性紅斑狼瘡適應症藥物臨床試驗批准通知書","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657414","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667657414?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:23","pubTimestamp":1789381419,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业 公布，于2026年9月11日，创新药CMS-D001片获得中国国家药品监督管理局签发的药物临床试验批准通知书，于2026年9月14日收到药物临床试验批准通知书。NMPA同意集团开展临床试验以评价CMS-D001治疗系统性红斑狼疮适应症的有效性和安全性。CMS-D001作为高选择性TYK2抑制剂，相较于泛JAK抑制剂，CMS-D001对其他JAK家族激酶的影响较小，可在长期疾病控制中维持疗效并降低相关安全风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495742.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BYV24P56.USD","IE00BVYPNQ40.USD","BMED","SG9999004311.SGD","PSYK","BK1161","LNGR","IBBJ","SG9999015986.USD","LU2488822045.USD","159992","00867","06978","IE00BMCWC346.EUR","SG9999015945.SGD","SG9999015952.SGD","BK1574","BK1593","IE00BVYPNP33.GBP","IBBQ","MEDX","BK1191","SG9999004220.SGD","IE00BGHQDM52.EUR","SG9999015978.USD","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667657480","title":"康哲藥業：9月14日CMS-D001獲SLE臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657480","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667657480?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 18:23","pubTimestamp":1789381383,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4077","IBBJ","BMED","SLE","MDTX","PSYK","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}